| Dr Simaan Shini, OD | |
|
1796 Graham Rd, College Station, TX 77845-9610 | |
| (979) 694-2000 | |
| (979) 694-2010 |
| Full Name | Dr Simaan Shini |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 20 Years |
| Location | 1796 Graham Rd, College Station, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093828436 | NPI | - | NPPES |
| 6652 TG | Other | TX | LICENSE |
| 81343Q | Other | TX | BCBS ID |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shini Od Pa | 2163575481 | 2 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of clinical research demonstrating for the first time that an advanced prebiotic (Bimuno) has the ability to reduce anxiety.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the stroke or traumatic event.
› Verified 3 days ago
| Provider Name | Shini Od Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083862213 PECOS PAC ID: 2163575481 Enrollment ID: O20090804000821 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of clinical research demonstrating for the first time that an advanced prebiotic (Bimuno) has the ability to reduce anxiety.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the stroke or traumatic event.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Simaan Shini, OD 3525 Longmire Dr Ste K, College Station, TX 77845-5281 Ph: (979) 694-2000 | Dr Simaan Shini, OD 1796 Graham Rd, College Station, TX 77845-9610 Ph: (979) 694-2000 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of clinical research demonstrating for the first time that an advanced prebiotic (Bimuno) has the ability to reduce anxiety.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the stroke or traumatic event.
› Verified 3 days ago
Vision Insight Corporation Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1405 Earl Rudder Fwy S, College Station, TX 77845 Phone: 979-764-7700 Fax: 979-764-7701 | |
Kathryn L Yorke, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2551 Texas Ave S Ste B, College Station, TX 77840 Phone: 979-764-0669 Fax: 979-694-1940 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1505 University Dr E Ste 450, College Station, TX 77840 Phone: 979-431-6053 | |
Dr. Michael C. Brice, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1700 University Dr E, College Station, TX 77840 Phone: 979-691-3300 | |
Dr. Don W. Nicholson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1700 University Dr E, College Station, TX 77840 Phone: 979-691-3300 Fax: 979-691-3527 | |
Dr. Justin Mays, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1109 Rock Prairie Rd Ste 300, College Station, TX 77845 Phone: 979-764-0669 Fax: 979-694-1940 | |
Dr Ann L Wild, Optometrist Optometrist Medicare: Medicare Enrolled Practice Location: 2746 Longmire Dr, College Station, TX 77845 Phone: 979-764-1554 Fax: 979-694-2259 |